EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease

Ayesha Asim, Michał K Jastrzębski, Agnieszka A Kaczor iD

Molecules · 15.07.2025 · 30 (14) · 2975

DOI: 10.3390/molecules30142975 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 15.07.2025. Verfasst von Ayesha Asim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical Universi…. Hauptthemen laut MEDLINE: Alzheimer Disease, Monoamine Oxidase Inhibitors, Cholinesterase Inhibitors, Monoamine Oxidase. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a multi-factorial neurodegenerative disease with a complex pathomechanism that can be best treated with multi-target medications. Among the possible molecular targets involved in AD, acetylcholinesterase (AChE) and monoamine oxidase B (MAO-B) are well recognized because they control the neurotransmitters responsible for memory processes. This review discusses the current understanding of AD pathology, recent advances in AD treatment, and recent reports in the field of dual AChE/MAO-B inhibitors for treating AD. We provide a classification of dual inhibitors based on their chemical structure and describe active compounds belonging to, i.a., chalcones, coumarins, chromones, imines, and hydrazones. Special emphasis is given to the computer-aided strategies of dual inhibitors design, their structure–activity relationships, and their interactions with the molecular targets at the molecular level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMonoamine Oxidase InhibitorsCholinesterase InhibitorsMonoamine OxidaseAcetylcholinesteraseHumansStructure-Activity RelationshipAnimalsMolecular Structure

Stichwörter der Autor:innen

Acetylcholine Esterase (AChE)Monoamine Oxidase-B (MAO-B)SARdual inhibitorsmolecular modeling

Substanzen

Monoamine Oxidase InhibitorsCholinesterase InhibitorsMonoamine OxidaseAcetylcholinesterase

Autor:innen und Institutionen

  • Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki St., PL-20093 Lublin, Poland.
  • School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, FI-70211 Kuopio, Finland.

ORCID-Profile: Agnieszka A Kaczor

Förderung

  • National Science Center

Zitieren

APA

Asim, A., Jastrzębski, M. K., & Kaczor, A. A. (2025). Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease. Molecules, 30(14), 2975. https://doi.org/10.3390/molecules30142975

Vancouver

Asim A, Jastrzębski MK, Kaczor AA. Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease. Molecules. 2025;30(14):2975. doi:10.3390/molecules30142975

BibTeX
@article{Asim2025,
  author = {Asim, Ayesha and Jastrzębski, Michał K and Kaczor, Agnieszka A},
  title = {Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {14},
  pages = {2975},
  doi = {10.3390/molecules30142975}
}
Kostenlos starten →